Artia Global Partners LP Merck & Co., Inc. Transaction History

Artia Global Partners LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$123.8 - $132.96 $7.84 Million - $8.42 Million	63,304 Added 16.69%	442,504 $54.8 Billion
Q1 2024 May 15, 2024	BUY	$113.24 - $131.95 $5.66 Million - $6.6 Million	50,000 Added 15.19%	379,200 $50 Billion
Q1 2023 May 15, 2023	BUY	$102.94 - $114.86 $6.69 Million - $7.47 Million	65,000 Added 24.6%	329,200 $35 Billion
Q4 2022 Feb 14, 2023	BUY	$87.44 - $112.11 $23.1 Million - $29.6 Million	264,200 New	264,200 $29.3 Billion

3,827

1.87B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $251B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Artia Global Partners LP, based on Form 13F filings with the SEC.

Stay updated on Artia Global Partners LP with notifications on news.